RTTNews | Oct 12, 2021 07:38AM EDT

07:37 Tuesday, October 12, 2021 (RTTNews) - Inhibrx : Phase 1 Trial Of INBRX-101 Shows Potential To Achieve Normal Alpha-1 Antitrypsin Levels With Monthly Dosing

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved